Loading...

This enables the engineering of these chronic cells that could avoid rejection by host T-cells and other immune cells. And they kill cancer cells better and they're also much, much safer. In tests using mice with humanized immune systems, the newly engineered cells successfully destroyed most cancer cells while avoiding attack from the host's own immune defenses.